DPAM
BIO icon

Degroof Petercam Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Degroof Petercam Asset Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$216K Hold
625
– – ﹤0.01% 592
2023
Q4 		$202K Buy
+625
New +$196K ﹤0.01% 595

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Degroof Petercam Asset Management's BIO Position: Q1 2024 in Review

Degroof Petercam Asset Management held its Bio-Rad Laboratories Class A (BIO) position steady in Q1 2024 at 625 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #592.

Degroof Petercam Asset Management first reported a position in BIO in Q4 2023 and has held it in 2 quarters since. 467 funds tracked by Wall St. Rank hold BIO as of Q1 2024.

  • Degroof Petercam Asset Management held 625 shares of Bio-Rad Laboratories Class A worth $216K as of Q1 2024.
  • Degroof Petercam Asset Management left its Bio-Rad Laboratories Class A share count unchanged in Q1 2024.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Degroof Petercam Asset Management's portfolio in Q1 2024, its #592 holding.
  • Degroof Petercam Asset Management first reported a position in Bio-Rad Laboratories Class A in Q4 2023 and has held it in 2 quarters since.
  • 467 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2024.

Based on Degroof Petercam Asset Management's 13F filing for Q1 2024, filed 13 May 2024.